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Abstract
Enlarged ventricles and reduced cortical volume are neuroanatomical abnormalities
correlated with schizophrenia and typically more severe in males. The MAM model of
schizophrenia is a developmental disruption model that involves exposing animals to a teratogen,
methylazoxymethanol acetate (MAM), to reflect the neuroanatomical traits of schizophrenia.
Rodents exposed to MAM on embryonic day 17 (E17) experience a reduction of cortical volume
and increased ventricular volume. Measuring brain weight and ventricular volume can be used to
inversely measure the severity of cortical reduction. The circling method was used to measure
the lateral ventricles of a sample of 27 rodents; 8 MAM-females, 7 MAM-males, 5 control
females, and 7 control males. The body weights of all subjects were recorded for 12 weeks.
There were significant effects of sex, time, and treatment on body weight as well as significant
time by treatment and time by sex interactions. Rodents exposed to MAM had lower body
weight throughout the 12-week period and, after puberty, the females of both the control group
and MAM group had lower body weight than male counterparts. Significant effects of sex and
treatment were also found on brain weight. The rodents exposed to MAM had lower average
brain weight than the control groups. Finally, there was a significant interaction of sex and
treatment on ventricular volume. Male rodents exposed to MAM had greater ventricular volume
than all other groups, respectively. These results reflect a similar pattern of ventricular
enlargement and cortical reduction to that seen in humans diagnosed with schizophrenia.
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Sex Differences in the Anatomy of MAM E17 Treated Rats: A Developmental Model of
Schizophrenia
This study uses the Methylazoxymethanol acetate (MAM) developmental disruption
model of schizophrenia to examine sex differences in the effects of exposing rodents to a
neurotoxin (MAM) on gestational day 17. Rodents who experience prenatal exposure to MAM
develop behavioral and anatomical abnormalities that reflect the pathology of schizophrenia. To
gain insight on the possible pathological origin of sex differences observed in schizophrenia, this
study uses the MAM model to analyze ventricular volume, brain weight, and body weight in a
sample of female and male rodents.
Pathology of Schizophrenia
Schizophrenia is a complex mental disorder that is characterized by a combination of
behavioral, cognitive, and anatomical traits. The likelihood of developing schizophrenia in one’s
lifetime is approximately 4.0/1,000 (Bhugra, 2005). According to a systematic review on the
epidemiology of schizophrenia, the proportion of individuals diagnosed with schizophrenia
within a population may vary depending on sex, migration status, and geographic location
(McGrath et al., 2008). The cause of this disorder is still unclear, but research suggests it is the
product of complex genetic and environmental interactions (Stilo & Murray, 2019).
The behavioral characteristics associated with schizophrenia are typically referred to as
positive and negative symptoms. Data from the Clinical Antipsychotic Trials of Intervention
Effectiveness (CATIE) research showed that roughly 19% of patients diagnosed with
schizophrenia display prominent negative symptoms, 20% display prominent positive symptoms,
and 21% display both negative and positive symptoms (Rabinowitz et al., 2013). Positive
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symptoms, otherwise referred to as psychotic symptoms, are symptoms that are added to typical
behavior such as hallucinations and delusions. Negative symptoms are behavioral and emotional
deficits that fall into two domains: reduced expression of emotions and reduced pleasure and
motivation (Blanchard & Cohen, 2005). According to the Brief Negative Symptom Scale
(BNSS), these symptoms include flat affect (emotionless face), alogia (limited speech),
asociality, anhedonia (lack of pleasure), and avolition (lack of motivation) (Kirkpatrick et al.,
2010). These symptoms are considered negative because they are the result of typical behaviors
being subtracted or taken away.
Cognitive symptoms of schizophrenia are similar to negative symptoms, as they are both
deficits, but these symptoms concern mental processes such as memory and executive
functioning rather than behavior. Cognitive impairment is one of the core traits of schizophrenia,
affecting approximately 73% of those diagnosed (Palmer et al., 1997). Studies using the
Wisconsin Card Sorting Test (WCST) have shown that patients with schizophrenia also struggle
significantly with cognitive flexibility, which is the ability to adapt to rules that change (Everett
et al., 2001). In addition, individuals with schizophrenia are observed to have impaired memory
consolidation during sleep (Wamsley et al., 2012). The Measurement and Treatment Research to
Improve Cognition in Schizophrenia evaluation, established by the National Institute on Mental
Health (NIMH-MATRICS), identifies seven major areas of cognitive impairment associated with
schizophrenia: working memory, attention/vigilance, verbal learning and memory, visual
learning and memory, reasoning and problem solving, processing speed, and social cognition
(Green et al., 2004). Behavioral and cognitive symptoms are linked to the frontal lobe
abnormalities associated with schizophrenia (Mubarik & Tohid, 2016).
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Anatomical differences in individuals affected by schizophrenia can be seen before and
after behavioral symptoms appear. Lane and Albee (1966) found that lower weight at birth is
associated with increased risk of developing schizophrenia. Later research supported this finding,
showing that individuals who developed schizophrenia were more likely to be underweight at
birth, throughout childhood, and after puberty (Sugawara et al., 2018; Wahlbeck et al., 2001).
Differences in body weight seen in schizophrenia are theorized to be due to disruptions during
development (Wahlbeck et al., 2001).
Significant physical abnormalities that are linked to schizophrenia can also be seen in
specific structures of the brain. Reduced brain volume is a common feature of schizophrenia
(Haijma et al., 2012; Vita et al., 2006). The reduction of brain volume is concentrated in regions
of the cerebral cortex, the wrinkled outer layer of the brain, that play a major role in the cognitive
functions impaired by schizophrenia. Research using MRI brain imaging suggests that the frontal
lobe and medial temporal lobe structures, such as the hippocampus and basal ganglia, tend to be
significantly reduced in volume in individuals diagnosed with schizophrenia (Wright et al.,
2000). These areas of the brain are important for memory and executive functioning. Another
common feature of schizophrenia is ventricular enlargement, which is the increase in volume of
the lateral ventricles (Johnstone et al., 1976; Vita et al., 2006; Wright et al., 2000). The lateral
ventricles are part of the brain’s ventricular system. The ventricular system is made up of spaces
within the brain filled with cerebrospinal fluid, which act as cushions for the brain and carry
nutrients. More recent meta-analytic evidence shows that ventricular enlargement increases over
time (Kempton et al., 2010). Since there is limited space inside the cranium, the ventricles likely
increase in volume to compensate for the cortex decreasing in volume over time. Therefore,
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evidence of progressive ventricular enlargement is indirect evidence of progressive cortical
reduction.
Anatomical features of schizophrenia, such as ventricular enlargement and cortical
reduction, are associated with the severity of cognitive impairment (Johnstone et al., 1976).
Progressive cortical reduction, the decrease in volume of the cerebral cortex over time, in the
brains of individuals diagnosed with schizophrenia is associated with increasing severity of
cognitive impairment over time; as the cerebral cortex shrinks, the cognitive symptoms increase
in severity (Kubota et al., 2015; Johnstone et al, 1976). Severity of cognitive impairment and
negative behavioral symptoms is also positively correlated with increases in ventricular volume
(Cahn et al., 2006; Haijma et al., 2012; Johnstone et al., 1976). Ventricular volume is negatively
associated with cortical volume, meaning that those who experience a reduction of cortical
volume are also found to have significantly larger ventricles (Arango et al., 2008). These
findings show that volumetric measurement of the lateral ventricles can be used to predict both
the extent of cortical reduction as well as the severity of cognitive impairments in those affected
by schizophrenia. This study uses the measurement of the lateral ventricles, along with brain
weight, as a way to indirectly measure cortical reduction.
Sex Differences in Schizophrenia
Research on sex differences in schizophrenia has been extensive but does not produce
much consensus. Ultimately, the interaction between sex and pathology of schizophrenia is still
ambiguous due to inconsistencies in methodologies and sample sizes across studies (Goldstein,
1993). Many studies include fewer female patients, which may lead researchers to erroneously
conclude that there is no significant difference in the way schizophrenia manifests in females and
males. Moreover, many studies involving animal models purposefully exclude female subjects
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because of the confounding effects of sex hormones such as estrogen. Still, there is some
consistent evidence of behavioral and anatomical sex differences in schizophrenia.
The most frequently studied sex differences concern behavioral symptoms. Females tend
to experience later onset of symptoms compared to males, but the overall prevalence of
schizophrenia is not significantly different for females and males (Jablensky et al., 1992; Kao et
al., 2013). Females diagnosed with schizophrenia tend to experience more positive symptoms
(auditory hallucinations and delusions of persecution) and are more responsive to antipsychotic
medication (Leung & Chue, 2000). Males tend to experience more severe negative symptoms,
such as deficits in social functioning, before and after being diagnosed with schizophrenia
(Canuso & Pandina, 2007; Rietschel et al., 2015). Interestingly, poor cognitive functioning in
males diagnosed with schizophrenia is related to the severity of anatomical abnormalities, but not
in females diagnosed with schizophrenia (Gur et al., 2000).
Neuroanatomical differences between males and females diagnosed with schizophrenia
are not as consistently replicated as behavioral sex differences. Several studies suggest that there
are not significant sex differences in anatomical traits of schizophrenia (Flaum et al., 1995;
Wright et al., 2000). However, others have argued that males have more severe neuroanatomical
abnormalities (Gur et al., 2000; Leung & Chue, 2000; Nopoulos et al., 1997). One difference that
is consistently supported by empirical research is that males diagnosed with schizophrenia
typically have significantly greater ventricular volume than females diagnosed with
schizophrenia (Arango et al, 2008; Nopoulos et al., 1997). The current study analyzes sex
differences in ventricular volume using a developmental animal model of schizophrenia in order
to better understand sex differences observed in humans with schizophrenia.
Etiology of Schizophrenia
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Schizophrenia is not caused by one single factor. This complicated disorder is theorized
to be the result of many genetic and environmental factors (Stilo & Murray, 2019). There is
evidence of a strong genetic component in developing schizophrenia; several genes have been
identified and shown to increase the risk (Prata et al., 2019; Schizophrenia Working Group of the
Psychiatric Genomic Consortium, 2014). In addition, certain environmental factors that can
increase the risk of developing schizophrenia have also been identified. Factors that can increase
the probability of an individual developing schizophrenia, especially in combination with genetic
factors, include childhood trauma, low socioeconomic status at birth, immigration, living in
urban areas, and complications during pregnancy and birth (Bourque et al., 2010; Cannon et al.,
2002; Harrison et al., 2001; Varese et al., 2012; Vassos et al., 2012). Complications during
pregnancy can disrupt typical brain development, which may lead to abnormalities in the brain
during adulthood. For example, prenatal maternal infection has been found to increase the risk of
developing schizophrenia as an adult (Buka et al., 2001). Even more, the neurons of people
diagnosed with schizophrenia tend to show a pattern of disorganization that can only be the
result of a disruption in the neuromigration that occurs during the second trimester of pregnancy
(Scheibel & Kovelman, 1981). Findings on the correlation between prenatal injury and the
development of schizophrenia serve as the basis for many neurodevelopmental theories of
schizophrenia.
Due to ethical and practical reasons, neurodevelopmental theories of schizophrenia are
often studied through the lens of animal models. According to the ethical principles of
psychologists established by the American Psychological Association (n.d.), researchers must
make an effort to minimize the harm done to human participants. Abiding by these standards,
humans cannot be intentionally exposed to a chemical that disrupts the development of the
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nervous system. Further, there are too many confounding variables to investigate a causal link
between accidental exposure to such chemicals and the development of schizophrenia. It is for
these reasons that controlled laboratory experiments using animal models are used to investigate
the role that prenatal brain injury plays in the development of brain abnormalities similar to those
seen in schizophrenia.
There are a multitude of theories and animal models used to study the potential causes
and the development of schizophrenia. Animal models are generally divided into four categories:
drug-induced, genetic, lesion, and developmental (Jones et al., 2011). Drug-induced models
typically involve the administration of drugs that produce schizophrenia-like behaviors in
animals. For example, repeated administration of stimulants, such as amphetamines, or
dissociative anesthetics, such as PCP, impairs cognitive functioning, learning, and social
behavior in ways that mimic schizophrenia (Mouri et al., 2007). Genetic models involve
identifying and altering genes in a way that increases the likelihood of developing traits
comparable to schizophrenia. For example, the Disc1 genetic model is commonly used to study
schizophrenia using mice and rats. Disc1 is a gene that is suggested to play an important role in
neuromigration during prenatal brain development, which further supports the theory that
schizophrenia has a developmental etiology (Hikida et al., 2007; Kvajo et al., 2008). Lesion
models involve causing damage to small regions of the brain early in life that cause cognitive
and behavioral traits that are reflective of the symptoms of schizophrenia, such as impairments in
working memory produced by neonatal lesioning of the hippocampus (Lipska & Weinberger,
2000). Developmental animal models include exposure to teratogens, chemicals that disrupt
typical development, during gestation in order to produce effects that mimic the pathology of
schizophrenia. The prenatal immune activation model is based on maternal exposure to the
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influenza virus during pregnancy (Brown & Derkits, 2010; Buka et al., 2001). The MAM E17
model involves maternal exposure to methylazoxymethanol acetate on day 17 of pregnancy in
rodents (Lodge & Grace, 2009).
Compared to other models, the MAM E17 developmental disruption model reflects the
complex behavioral, physiological, and neuroanatomical features of schizophrenia most
accurately (Modinos et al., 2015). Drug-induced models of schizophrenia fail to address the
developmental aspect of the disorder. Genetic models have not shown that there is a specific
genetic alteration that always leads to the development of schizophrenia, although many genes
have been linked to a greater likelihood of developing the disorder (Harrison & Weinberger,
2005). Lastly, lesion models lack validity because although the behavioral and cognitive effects
may reflect schizophrenia, there is no evidence that people diagnosed with schizophrenia
develop lesions in their brains. Other animal models may reflect a portion of the pathological
profile of schizophrenia, but the MAM developmental model provides the most comprehensive
array of symptoms that mirror schizophrenia. The MAM model shows that prenatal exposure to
MAM leads to an overactive dopamine system, abnormal functioning in the hippocampus and
frontal lobes, progressive cortical reduction, increased neuronal density, increased response to
stimulants, and cognitive dysfunction, all of which are traits of schizophrenia (Lodge & Grace,
2009, 2010, 2012).
The MAM Model of Schizophrenia
The MAM model of neurodevelopmental disruption uses rodent subjects to make
inferences about the development of schizophrenia in humans and has received wide empirical
support. This model was first developed by neuroscientists Dr. Daniel J. Lodge and Dr. Anthony
A. Grace (2010) and is commonly used in research today.
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Methylazoxymethanol acetate (MAM) is a DNA methylating agent that targets the
central nervous system and disrupts the division of cells. DNA methylation is an epigenetic
mechanism that involves directly interfering with the DNA and results in modification of gene
expression (Moore et al., 2012). MAM is a controlled substance that humans do not typically
encounter in the environment but can be found in the seeds of some cycad plants (Nair & van
Staden, 2012). To produce the intended effects, it is necessary to expose rodent subjects to MAM
on gestational day 17 (E17), which is the point during the embryonic period when cortical
structures are being developed and subcortical structures are mostly complete in their
development (Lodge, 2013; Moore et al., 2006). If MAM is exposed to subjects at any other
time, such as embryonic day 15 (E15), the resulting neuroanatomical effects are severe and
reflect global brain damage but do not reflect the disruption to specific brain areas associated
with schizophrenia (Lodge, 2013). When MAM is administered on E15, the reduction of the
whole brain, hippocampus, and cerebellum volume is far more severe than what would reflect
the morphological traits of schizophrenia (Johnson et al., 2006). When this neurotoxin is exposed
to rodents on gestational day 17, it induces behavioral, physiological, and anatomical symptoms
that mirror the pathology of schizophrenia (Lodge & Grace, 2009).
The behavioral effects of exposure to MAM are similar to the cognitive and negative
symptoms observed in schizophrenia. Research shows that male rats exposed to MAM on E17
show decreased social interaction and difficulties with learning and cognitive flexibility tasks
(Lodge & Grace, 2009). Impaired cognitive flexibility is the tendency to continue making
incorrect responses during tasks, this is often referred to as preservative responding and is also
seen in individuals affected by schizophrenia (Everett et al., 2001). These behavioral effects are
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linked to the abnormalities in brain functioning that are caused by exposure to the teratogen
MAM.
Administration of MAM on embryonic day 17 also impacts the physiology of rodent
brains. Male mice exposed to MAM are observed to have decreased size and function of the
hippocampus and show decreased function of the prefrontal cortical region (Chalkiadaki et al.,
2019). The hippocampus and prefrontal cortical region are important for working memory and
visuospatial tasks, which can be measured in rodents using water mazes. The male mice exposed
to MAM made more mistakes in the mazes, which is indicative of the decreased function and
size of these cortical regions (Chalkiadaki et al., 2019). These effects are similar to the
neurophysiological abnormalities typically seen in individuals diagnosed with schizophrenia.
The structural effects of developmental disruption caused by MAM also reflect structural
abnormalities seen in humans with schizophrenia. Male MAM E17-treated rodents are found to
have significantly reduced cortical volume in regions that parallel the cortical reduction observed
in humans affected by schizophrenia (Chalkiadaki et al., 2019; Lodge et al., 2009; Moore et al.,
2006). Chin and colleagues (2010) found that male rodents exposed to MAM also have increased
ventricle size. Ventricular enlargement and cortical reduction are both features typical of
schizophrenia (Haijma et al., 2012; Johnstone et al., 1976; Vita et al., 2006; Wright et al., 2000).
There is evidence that males diagnosed with schizophrenia have more severe ventricular
enlargement than females (Arango et al, 2008; Nopoulos et al., 1997), but this has not been
studied using the MAM model.
Using the MAM Model to Study Sex Differences in Anatomy
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To examine the anatomical sex differences in the MAM model of schizophrenia, this
study compares data from 27 rodents. Evidence shows that there are sex differences in the
pathology of schizophrenia, but few studies have used animal models to examine the significance
or cause of these sex differences. The variables analyzed included the average volume of the left
and right lateral ventricles in cubic millimeters, the postmortem brain weight in milligrams, and
the body weight measured in grams over a span of 12 weeks. In this study we investigate the
following question: are there significant sex differences in average ventricular volume and
average brain weight between of rodents exposed to the teratogen MAM? The rodents will be
divided into four groups based on sex and treatment: females exposed to MAM, males exposed
to MAM, control females, and control males. We hypothesized that the male rodents exposed to
the teratogen MAM would have an average ventricular volume significantly greater than females
exposed to MAM and the male controls.
Method
Preparation of Tissue Samples
The tissue samples used in this research project were derived from a past study conducted
by Dr. Stephanie Penley, Professor of Psychology at Wheaton University, with IACUC approval
(#95-2016). No live animal subjects were involved in the following research.
Dr. Stephanie Penley’s study “E17 MAM Exposure and Working Memory'' (in
preparation) was conducted at Wheaton College in Massachusetts from 2016 to 2019. This
research involved nine female Sprague-Dawley (albino) rats, also referred to as “dams”. On
gestational day 17 (GD17, E17, or 17 days into pregnancy) five of the dams received an
intraperitoneal, or abdominal, injection of methylazoxymethanol acetate (MAM). MAM is a
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toxin that causes long-term behavioral and neuroanatomical effects by disrupting the division of
cells within the central nervous system. Following birth, the MAM-exposed and control pups
were culled and sorted into litter sizes of 10, with an even number of males and females in each
litter. This was necessary to control for the maternal behavior and hormonal levels among the
pups. A final sample size of 22 was used for the MAM groups and 18 for the control groups with
equal number of males and females were included in each condition (control male = 18, control
female = 18, MAM-male = 22, MAM-female = 22). The rats were single housed during
pregnancy and weaning in BPA-free polycarbonate cages. After weaning, the animals were pair
housed. The temperature was maintained at 21± 2°C, food and water were available ad libitum
and the lights were maintained on a 14:10 light cycle with lights going on at 7:00 a.m.
The dams produced a total of 80 offspring, each with a unique identification number. Due
to time constraints, the tissue samples from only 27 of the total 80 offspring were analyzed. All
offspring were weaned from their mothers on postnatal day 21 (P21 or 21 days after birth). The
body weight of each rodent was recorded in grams for 12 successive weeks beginning on P21
until P95. Every day the activity levels, food consumption, and general well-being of all animal
subjects were monitored by Dr. Penley and colleagues.
After reaching developmental maturity around postnatal day 95, the rodents were
euthanized by receiving a lethal dose of pentobarbital, a barbiturate that inhibits the central
nervous system. The subjects were then given a transcardial perfusion of 0.9% saline and 4%
paraformaldehyde; this procedure utilizes the vascular system of the anesthetized animal subject
to circulate a chemical that acts as a fixative and preservative for tissue. Following chemical
euthanasia and absence of all signs of life, cervical dislocation (decapitation) was used as a
secondary method of confirming the sacrifice of all animal subjects.
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Surgery was then performed to remove the brains of all animal subjects. The brains of
each subject were stored in paraformaldehyde and 10% sucrose (cryoprotectant) in preparation to
be divided into sections for analysis. Using a cryostat machine, the brains of the animal subjects
were sectioned into sequential coronal slices. A cryostat machine freezes the preserved tissue at 24°C and uses a microtome, a sharp rotating blade within the machine, to cut the tissue into
extremely thin slices. Coronal sections, which divide the tissue vertically from front to back,
were used to aid in the visualization and measurement of brain structures. Each section of brain
tissue is 50 micrometers thick. Adhering to the technique established by Simpson and Vicario
(1991), every fifth section was stored for analysis. Using a sampling interval of 5 (every fifth
section) to measure volume rather than all sections has been shown to be significantly more
efficient without compromising accuracy (Gundersen & Jensen, 1987). Sections being kept for
microscopic analysis were mounted on glass slides with a clear fixative (Permount) and Nissl
stained. Nissl staining involves the application of (0.1%) Thionin to tissue samples. Thionin is a
chemical dye that improves the visualization of brain structure by coloring the DNA and RNA of
each nerve cell a dark blue.
Out of the 80 offspring produced, 27 were chosen randomly and analyzed in the
following study. In order to remain unbiased, the sex and treatment of the subjects were not
disclosed during the data collection phase of the study. For the purpose of data analysis, the 27
subjects were divided into four groups: Group 1 included 8 female offspring exposed to MAM
(MAM-females), Group 2 included 7 male offspring exposed to MAM (MAM-males), Group 3
included 5 non-exposed female offspring (control females), and Group 4 included 7 non-exposed
male offspring (control males). Data from all subjects was collected using the circling method, as
described below.
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Measurement of Lateral Ventricles
The circling method refers to a technique involving the use of image processing software
to carefully trace the border of a specific region of the brain (Grisham & Arnold, 1995; Grisham
et al., 2008; Simpson & Vicario, 1991). The software AmLite was paired with a digital
microscope to take photographs of each section of tissue. ImageJ, the software used for
microscopic analysis in the current study, is able to calculate the area of a circled region in
millimeters squared. After measuring the area of the lateral ventricles in each successive section
of the brain, the sum of these areas is multiplied by both the thickness of the slice and the
sampling interval. The thickness of the slices (50 μm or 0.5 mm) is multiplied by the sampling
interval (5) to produce the multiplier 0.25 mm. The stereological (three dimensional) formula
used to estimate the volume of the entire lateral ventricle is: VOLUME mm³ = SUM OF AREAS
mm2 * 0.25 mm.
The lateral ventricles are one set of the four cerebral ventricles within the brain’s
ventricular system. Ventricles are interconnected cavities containing choroid plexus, which
produces the cerebrospinal fluid that fills the ventricular system and carries nutrients throughout
the brain. Anatomical points on the rodent skull (Bregma, the coronal suture, and the sagittal
suture) and internal brain structures were used to determine the point within the brain where
measurement of the lateral ventricles will begin and end. Bregma is the intersection of the
coronal suture and sagittal suture on the top of the rodent skull. The coronal suture is a line from
left to right on the skull that marks the joining of the front-facing frontal bone from the parietal
bones on the left and right sides of the skull. The sagittal suture of the skull intersects
perpendicularly with the coronal suture then recedes to the back of the skull and marks the
joining of the parietal bones on either side of the skull. Using the Bregma intersection as a
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reference point, the distance that the lateral ventricles span within the brain can be described
using millimeters. The point at which measurement of the lateral ventricles began is
approximately Bregma +2.76 mm (2.76 mm in front of Bregma), where the lateral ventricles
begin to appear in the serial coronal sections of the typical rat brain (Paxinos & Watson, 2014).
The established end point for measurement is the point at which the lateral ventricles of the
typical rodent brain are no longer visible, approximately Bregma -4.92 mm (4.92 mm behind
Bregma). These operational definitions help reduce the subjectivity of measurements. The lateral
ventricles will be distinguished from other brain structures based on the relative position, shape,
and cytoarchitecture. The borders of the ventricles are defined by a dense line of cells that appear
darker than the surrounding neurons. Inside this border the ventricles are mostly acellular, except
for small amounts of dark-pigmented choroid plexus cells. In the instance that the lateral
ventricles on one section of tissue were damaged or otherwise unable to be measured, the
ventricular volumes of the previous slide and next slide were averaged and used in data analysis.
Figure 1 below depicts a coronal section of a rodent brain viewed under a microscope where the
lateral ventricle is circled in yellow.
Figure 1
Coronal Section of Rodent Brain Highlighting the Lateral Ventricles
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Note: This image depicts a coronal section of a rodent brain at approximately Bregma –0.12 mm.
Highlighted in yellow is the left lateral ventricle (seen on the right side as the brain is facing
forward). Within the lateral ventricles is the choroid plexus, which is stained dark blue. The
choroid plexus is a type of epithelial cell that produces the cerebrospinal fluid that fills the
ventricles (Lun et al., 2015).
Data Analysis
Separate analyses were run to examine the effects of sex and treatment on brain weight,
body weight and lateral ventricular volume. As established by previous studies, nested ANOVA
tests were used to examine the interaction between sex and treatment effects (McClure et al.,
2006) after establishing that there were no significant birth cohort (dam) effects. To compare
brain weight differences, a 2 (sex) x 2 (treatment) nested ANOVA design was used. For
ventricular volume analysis, a nested design repeated measure ANOVA, 2 (sex) x 2 (treatment) x
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2 (repeated brain volume measurement) was used. Finally, for body weight a 2 (sex) x 2
(treatment) by 12 (repeated week measurement) ANOVA was used.
Results
Data analysis showed that the body weights of the rats were affected by sex, treatment,
and time. As previously stated, the rats were weighed once a week for a 12-week period. All rats
showed an increase in body weight across those 12 weeks. A 2 (sex) x 2 (treatment) x 12 (weeks)
design repeated measures ANOVA determined that there was a significant effect of time (in
weeks) on the body weight of all rodents, indicating that they increased in weight over time, F
(11, 253) = 1389.73, p < .001, ETA2 = .984. There was also a significant effect of sex on body
weight F (1, 23) = 155.91, p < .001, ETA2 = .871, and a week by sex interaction, F (11, 253) =
129.82, p < .001, ETA2 = .850, indicating that male and female rats grew at different rates. The
female rodents showed more than a 300% increase in body weight through the developmental
period (MAM-females = 371% increase and control females = 383%). As is expected based on
typical adult body size differences between males and female rats, male rats showed a greater
percentage increase in body weight from weaning (P21) through the end of the 12-week period
(P95), increasing more than 600% in body weight (MAM-males = 666% increase, control males
= 633% increase). The greater percentage increase in body weight of MAM-males may be due to
lower initial body weight at P21 (see Figure 2.)
Exposure to MAM had a significant impact on body weight over time. There was a
significant effect of treatment on body weight (F (1, 23) = 24.09, p < .001, ETA2 = .512) as well
as a week by treatment interaction (F (11, 253) = 8.68, p < .001, ETA2 = .274), indicating that
MAM had significant effects on body weight over time. After finding significant effects of both
sex and treatment as well as significant sex by week and treatment by week interactions, post hoc
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analyses were run. In line with previous studies, separate 2 (sex) x 2 (treatment) ANOVAs were
run to analyze the body weights at each of the 12 weeks (see McClure et al, 2006). From P21 to
P95, there was a significant effect of treatment on body weight, all p < .001. Beginning at
puberty (P32), there was a significant effect of sex on body weight at each week, all p < .001.
Each week, control males had the highest body weight (P21 through P95). The control females
had the second highest body weight on P21, P25, and P32, but after that the MAM males
consistently had the second highest body weight (P46 through P95). MAM females had the
lowest body weight each week. This data supports the hypothesis that sex and exposure to MAM
impact body weight over time. Figure 2 (below) displays the change in body weight among all
groups over time.
Figure 2
Postnatal (P) Body Weight from Weaning (Day 21) to Day
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Note: This graph depicts the changes in average body weights of the four groups over a period of
12 weeks, beginning at weaning on P21 (postnatal day 21) and ending on P95. The x-axis
represents postnatal age in days. The y-axis represents body weight in grams. The puberty period
for female rats is typically P32-P34, the puberty range for male rats is typically P45-P48
(Sengupta, 2013). After puberty, the average body weights of both control groups remain greater
than both MAM groups, respectively. Within the control groups, the females had consistently
lower average body weight. This difference is also found in the MAM groups. MAM-females
have the lowest average body weight at each of the 12 weeks. Asterisks represent a significant
effect of sex. Crosses represent a significant effect of treatment.
Similarly, brain weight was also impacted by exposure to MAM (treatment) and sex. To
compare brain weight differences, a 2 (sex) x 2 (treatment) nested ANOVA design was used.
The 2 x 2 ANOVA revealed that there was a significant effect of sex on brain weight, F (1, 23) =
11.53, p < .001, ETA2 = .334. We also found a significant effect of treatment on the brain weight
of the rodents, F (1, 23) = 45.54, p = .002, ETA2 = .664. Control males had the greatest brain
weight (M = 1.91 g, SEM = 0.04). Male rodents exposed to MAM had an average brain weight
that was 12.2% less than control males, with an average brain weight of 1.68 g (SEM = 0.02). As
predicted by differences in body weight, control females (M = 1.79 g, SEM= 0.04) had 6.4%
lower brain weight than control males. Similarly, MAM-females (M = 1.58 g, SEM = 0.02) had
an average brain weight that was less than that of control females, with a decrease of 16.9%.
Finally, MAM-males had a 5.4% increase compared to MAM-females. These results support the
prediction that brain weight is influenced by both sex and exposure to MAM. Figure 3 (below)
shows the average brain weights of all groups as well as the standard error of the means.
Figure 3
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Average Brain Weight

Note: This graph depicts the effects of both sex and exposure to MAM on average brain
weight of rats. The x-axis represents the four groups (MAM-females, MAM-males, control
females, and control males). The y-axis represents brain weight in grams. The brain weights of
both control groups are higher than both MAM groups, respectively. Within the control groups,
females had lower average brain weight. Similarly, within the MAM groups, MAM-females had
lower average brain weight.
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Statistical analysis showed that sex and treatment had an interactive effect on ventricular
volume. For ventricular volume analysis, a nested design repeated measure ANOVA 2 (sex) x 2
(treatment) x 2 (repeated brain volume measurement) was used to examine the influence of
MAM and sex on ventricular volume. The repeated measures analysis showed no significant
effect of volume measurement across left and right hemispheres for sex or treatment. There was
also no significant effect of sex or treatment between groups, however there was a sex by
treatment interaction, F (1, 23) = 7.496, p = .012, ETA2 = .246. Since there were no differences
between left and right hemispheres, we compared sex and treatment differences of the total
ventricular volume. The average ventricular volumes of MAM-males (M = 23.09 mm³, SEM =
2.27) was 32% greater than MAM-females (M = 15.60 mm³, SEM = 1.35). Further, the MAMmales had a greater ventricular volume than control males (M = 14.84 mm³, SEM = 2.53), with
MAM-males having 36% greater average ventricular volume than control males. Interestingly,
the ventricular volume of control females (M = 21.33 mm³, SEM =4.43) was greater than that of
MAM-females. This data indicates that exposure to MAM affects the ventricular volume of male
and female rodents differently. Figure 4 (below) shows the average ventricular volumes of all
groups as well as the standard error of the means.
Figure 4
Total Ventricular Volume
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Note: This graph depicts the effects of both sex and exposure to MAM on average
ventricular volume of rats. The x-axis represents the four groups (MAM-females, MAM-males,
control females, and control males). The y-axis represents average ventricular volume in mm³.
This figure combines left and right ventricular volume because no meaningful difference was
found between the hemispheres. There was a significant interaction of sex and treatment on
ventricular volume. This data suggests that exposure to MAM does not have the same effect on
the ventricular volume of male and female rats.
Discussion
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This study examined differences in the anatomy of male and female rats following
exposure to MAM on embryonic day 17. We are particularly looking at differences in the
neuroanatomical features that mimic schizophrenia. While several studies have examined the
impact of MAM, no other studies have made direct comparisons between males and females
exposed to MAM, and so this study offers novel insights to the field. Understanding sex
differences in the MAM model can help us gain a better understanding of the
neurodevelopmental model of schizophrenia and contribute to possible treatments.
As explained before, research has shown that people diagnosed with schizophrenia tend
to have reduced brain volume, increased ventricular volume, and lower body weight throughout
development (Haijma et al., 2012; Johnstone et al., 1976; Lane & Albee, 1966; Vita et al., 2006;
Wahlbeck, 2001; Wright et al., 2000). There is evidence that these anatomical abnormalities may
be the result of prenatal injury. For example, the hippocampal neurons of people diagnosed with
schizophrenia tend to show a pattern of disorganization that can only be the result of a disruption
in the neuromigration that occurs during the second trimester of pregnancy (Scheibel &
Kovelman, 1981). Similarly, male rodents that experience prenatal injury by being exposed to
MAM have also been shown to have disorganized hippocampal cells (Moore et al., 2006). Even
more, male rodents exposed to MAM have been shown to experience reductions in brain volume
as well as enlarged ventricles (Chalkiadaki et al., 2019; Chin et al., 2010; Lodge et al., 2009;
Moore et al., 2006). In line with previous findings, this study supports evidence that exposure to
MAM impacts brain volume, ventricular volume, and body weight of rats in a way that mimics
the anatomical traits correlated with schizophrenia. However, past research has not examined sex
differences in the anatomical effects of being exposed to MAM. Exposure to MAM affected the
body weight and brain weight of female and male rodents in a similar way, which suggests that
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gross measures may not be able to tease apart the subtle sex differences in the anatomical effects
of being exposed to MAM. In addition, this study found that exposure to MAM impacts the
ventricular volume of female and male rodents differently. This finding indicates that sex
differences in the neuroanatomical effects of MAM may be more subtle and should inform how
future studies examine these variables.
As previously stated, individuals diagnosed with schizophrenia are more likely to have
lower body weights at birth, before puberty, and after puberty (Lane & Albee, 1966; Sugawara et
al., 2018; Wahlbeck, 2001). In this study, the data indicates that exposure to MAM reduces body
weight at birth, before puberty, and after puberty in a way that is modulated by sex. Significant
reductions in growth (as measured by body weight over time) were seen following exposure to
MAM for both male and female rats. While sex differences in weight arose during puberty, with
male rats increasing weight more rapidly than their female counterparts, the effect of MAM was
maintained throughout development and into adulthood. Upon weaning, around 21 days after
birth (P21), both control groups had greater average body weight than both MAM groups. Until
puberty, the differences in body weight were primarily due to exposure to the teratogen MAM.
The puberty period in rodent development begins around postnatal day 32 (P32) (Sengupta,
2013). After puberty, the differences in body weight were the result of both exposure to MAM
and sex. After P32, both the control males and MAM-males had greater average body weights
than control females and MAM-females, respectively. From P32 until P95, there are statistically
significant effects of sex on the average body weights at each point of measurement. This is
evidence that the anatomical effects of MAM are present before and after puberty, which
replicates findings from Chin et al (2010). Lower body weight was consistently seen as an effect
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of exposure to MAM in both males and females, which is further evidence of the developmental
disruption caused by MAM.
In addition to changes in body weight, evidence shows that reduced brain weight is also
associated with schizophrenia (Cahn et al., 2002). Reduced brain weight can provide indirect
evidence of cortical reduction, a consistently observed trait of schizophrenia (Haijma et al., 2012;
Vita et al., 2006). Research using the MAM model of schizophrenia have also found reductions
in brain volume of male rodents (Chin et al., 2010; Lodge & Grace, 2009; Moore et al., 2006).
This study found that both sex and treatment influence brain weight. As is typical, male rats had
greater brain weights than female rats, which is reflective of differences in body weight.
Significant reductions in brain weight were seen in both MAM-males and MAM-females.
Importantly, previous studies did not include female rodents when examining the effects of
MAM on brain weight. The current study reveals that MAM caused similar reductions in the
brain weights of both male and female rodents. This data parallels findings of cortical reduction
in MAM-males, but findings on cortical reduction in MAM-females have not been replicated.
Ventricular enlargement is another anatomical feature that is typically found in people
diagnosed with schizophrenia (Johnstone et al., 1976; Vita et al., 2006; Wright et al., 2000).
Studies have shown that males diagnosed with schizophrenia tend to have greater ventricular
enlargement than females diagnosed with schizophrenia (Arango et al, 2008; Nopoulos et al.,
1997). Previous research has not used the MAM model to compare severity of ventricular
enlargement between female and male animals. The data analysis shows that there is an
interaction of sex and MAM treatment on the ventricular volume of rodents. The ventricular
volume of MAM-males increased while the ventricular volume of MAM-females decreased (see
Figure 3.) This data supports research conducted by Chin and colleagues (2010) which found
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that male rodents exposed to MAM experienced significant ventricular enlargement in both
hemispheres of the brain. The current findings suggest that female rodents, however, did not
experience significant ventricular enlargement. This is evidence that MAM impacts the
ventricular system of male and female rodents differently.
These results demonstrate that the difference in ventricular enlargement between male
and female rodents exposed to MAM on E17 may mirror the difference in ventricular
enlargement between male and female patients diagnosed with schizophrenia. This means that
the MAM-E17 model may be ideal for helping us to understand the anatomical differences
associated with schizophrenia. Further, it can allow for an avenue to specifically explore sex
differences following neonatal injury. This is important because there is evidence that cortical
injury during development affects males differently and tends to be more severe (Herman et al.,
1997; Hill & Fitch, 2012).
One possible explanation for these findings may be the theory that estrogens act as a
protective factor against neurodegenerative conditions such as schizophrenia. Previous metaanalytic research has proposed a hormonal component in the development and pathology of
schizophrenia as an explanation of why females diagnosed with schizophrenia typically have less
severe neuroanatomical features and tend to be diagnosed later in life, when estrogen levels are
lower (Leung & Chue, 2000). This leads to the hypothesis that higher estrogen levels can protect
against neurodegeneration and brain injury. To study this, the neuroprotective qualities of
estrogens have been demonstrated using other animal models of brain damage (Dluzen et al.,
1996; Miller et al., 1998; Sawada et al., 1998). There is evidence that hormones have the
potential to impact the severity of neonatal brain injury (Hill & Fitch, 2012). The interaction
between estrogens and the effects of prenatal injury have also been analyzed using the MAM
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model. Researchers have found that the estrogen cycle influences the functioning of the
dopaminergic system within the brains of female rodents exposed to MAM on E17, which can be
seen by recording the activity of neurons (Perez et al., 2014). The estrogen cycle also influences
other schizophrenia-like traits that are seen in female rodents exposed to MAM such as
hypersensitivity to stimulant drugs and abnormal social interaction (Perez et al., 2019). This
evidence implies that hormones influence the behavioral and physiological effects seen in the
MAM model of schizophrenia. No research to date has investigated whether hormones influence
the structural effects of MAM exposure.
The results of this study, as well as previous research (Hill & Fitch, 2012; Perez et al.,
2014, 2019), implicate that neuroanatomical sex differences may be due to differences in sex
hormones between MAM-males and MAM-females. It is unclear whether estrogen plays a
protective role or testosterone plays a maladaptive role when it comes to prenatal injuries. This
presents two avenues for future research: manipulating either estrogen or testosterone levels in
ovariectomized MAM-females. An ovariectomy is a procedure that involves removing the
ovaries of female rats, which then produces estrogen-deficient females. Since estrogen levels
vary depending on the individual and time during estrous cycle, ovariectomizing all female
subjects will act as a control measure. Replicating the design of this study, the anatomical effects
of MAM can then be compared between estrogen-deficient MAM-females and MAM-females
that have been administered a specific dose of estrogen. A replication of this study comparing the
effects of MAM in estrogen-deficient and estrogen-treated female rodents, instead of male and
female rodents, would be better able to isolate the potential protective effects of estrogen.
If estrogen acts as a neuroprotective factor, then the estrogen-deficient MAM-females
would experience more severe structural effects of prenatal injury. In this case, further studies
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can then attempt to replicate the protective effects of estrogen using male rodents exposed to
MAM. However, if estrogen does not modulate developmental disruption, then there would not
be significant differences between estrogen-deficient and estrogen-treated MAM-females. Future
studies should then focus on the effects of manipulating testosterone levels in estrogen-deficient
MAM-females to gain insight on the possible maladaptive effects of testosterone. Either outcome
will help to shed light on the sex differences in the anatomy of MAM-exposed rodents that were
revealed by this study. This research could help to reveal the ways in which the sex differences
in the MAM model of schizophrenia reflect the sex differences in the pathology of schizophrenia
in humans, potentially improving the validity of the MAM model. In addition, exploring this
topic further could reveal important interactions between hormones and brain injury that could
influence the study and treatment of other types of neurodegenerative disorders.
Limitations of this study include the accuracy of the measurement methodology. The
circling method of measurement provides a quick and valid estimation of three-dimensional
volume, but this method is not exact as it is based on tracing the perimeter of the region being
measured. Because each individual that uses the circling method of measurement will interpret
the border of the region differently, there is some subjectivity in this method. Additionally,
because it is reliant on outlining specific subjective borders, this method increases variability in
area measurements (Rosen & Harry, 1990). Going forward, a more precise measurement
methodology could be utilized to improve the reliability of results, such as Cavalieri’s pointcounting method. Point-counting is a stereological technique that is used to measure brain
structures by counting the points on a grid that fall within the region being measured. This
method depends on Cavalieri’s estimator of morphometric volume, which has previously been
shown to be a highly accurate mathematical measure of brain regions (Rosen & Harry, 1990).
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Cavalieri’s estimator requires the points being counted to be evenly spaced, so a grid is laid over
each slide of tissue being measured using ImageJ, the same software used in the circling method.
Each point on this grid that falls within the region being measured is counted to provide a
calculation of the area. The area of the region on each slide is then combined to produce an
estimate of volume. This method of measurement is also used in measuring structures within the
human brain (Arango et al., 2008). The point-counting method is slightly more accurate than the
circling method but takes considerably more time. The measurement method used in this study is
valid, but a more accurate method of measurement could reduce the variability of the
measurements, allowing for more subtle differences to be revealed.
Additionally, some sections of the tissue samples used were not able to be measured due
to damage that occurred while the tissue samples were being processed. In this case, an average
of the previous and following sections were used in data analysis. To avoid the potential
influence of results caused by damage, future studies could use magnetic resonance imaging
(MRI) images for measurement. MRI measurement takes place while the animal subject is still
alive, which could help avoid the issue of damaged or missing tissue samples. The use of MRI to
measure the ventricular volume of live rodents exposed to MAM has been used in previous
studies (Chin et al., 2010). This method also offers better access to information about how the
structures within the brain may change during development. Using this method, future
researchers could conduct a longitudinal study that tracks differences in behavioral and structural
effects of developmental disruption caused by MAM over time.
The generalizability of these results is also limited by the relatively small sample sizes.
With small samples it is difficult to determine whether the results represent the population being
studied. This study found that control females had greater average ventricular volume than
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control males and MAM-females, respectively. This group also had the greatest variability (see
Figure 4.) Although not statistically significant, this data was unexpected and may be due to
small sample sizes and the variability of the circling method. In addition, data analysis revealed
no significant effect of sex or treatment on ventricular volume. Further research with larger
samples may be able to reduce the variability within groups and find significant differences
where this study did not.
Conclusion
Significant effects of treatment and sex were found on the body weight and brain weight
of male and female rodents exposed to MAM. In addition, an interaction was seen between sex
and MAM exposure on ventricular volume. As predicted, rodents exposed to MAM experienced
a disruption in their development which led them to have lower body weight than control
rodents. The developmental disruption also affected the brain weight of the rodents exposed to
MAM; both MAM-males and MAM-females had lower brain weights than control males and
control females, respectively. However, exposure to MAM did not impact the ventricular volume
of male and female rodents in the same way.
This data contributes to a clearer understanding of how the sex differences in the MAM
model of schizophrenia reflect the sex differences in the pathology of schizophrenia. This study
is one of the first to directly compare female and male rodents exposed to MAM and contributes
novel data to the study of schizophrenia. Humans diagnosed with schizophrenia and rodents
exposed to MAM on E17 are found to have similar physical abnormalities (Chalkiadaki et al.,
2019; Chin et al., 2010; Lodge et al., 2009; Lodge & Grace, 2010, 2012; Moore et al., 2006). The
MAM model has been studied extensively, but few studies have focused on sex differences
within this model of schizophrenia. As previously discussed, schizophrenia presents differently
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in females and males (Arango et al., 2008; Canuso & Pandina, 2007; Gur et al., 2000; Leung &
Chue, 2000; Nopoulos et al., 1997; Rietschel et al., 2015). Further research using the MAM
model with both female and male subjects could help researchers gain insight on how sex
impacts the development and symptoms of schizophrenia, ultimately leading to improved
treatment and diagnostic tools. As further research strengthens the validity of the MAM E17
model of schizophrenia, opportunities to use this model to study new early-intervention or drug
therapies arise. As previously stated, very few studies that used the MAM model have included
female subjects. The results of this study show that exposure to MAM impacts male and female
rodents differently, so studies that test new treatments for schizophrenia using the MAM model
should include both male and female subjects. This would help predict potential sex differences
in how humans diagnosed with schizophrenia would respond to new treatments. Future research
focusing on female rodents within the MAM model and the potential modulating effects of
estrogen could develop novel therapeutic approaches specifically for female patients of
schizophrenia. Finally, gathering more information on the role that estrogens play in the MAM
model could potentially lead to hormone-based treatments for schizophrenia as well as other
neurodegenerative disorders, such as Alzheimer's disease or Parkinson’s disease.
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